Heparin Lithium salt 是一种抗凝剂，可与 抗凝血酶III (ATIII) 可逆地结合 (50-400 U/Kg)。
CAS：9045-22-1
分子式：(C14H25NO20S3)n.xLi
分子量：
纯度：98%
存储：Store at -20°C

Background:

Heparin Lithium salt is an anticoagulant which binds reversibly to antithrombin III (ATIII) (50-400 U/Kg). Antithrombin III[1]

Heparin is a potent anticoagulant drug based on its ability to accelerate the rate at which antithrombin inhibits serine proteases in the blood coagulation cascade. Heparin interactes most tightly with peptides containing a complementary binding site of high positive charge density. Heparin resembles DNA as both are highly charged linear polymers that behave as polyelectrolytes. Heparin is believed to function as an anticoagulant primarily through its interaction with AT III by enhancing AT-III-mediated inhibition of blood coagulation factors, including thrombin and factor Xa. Heparin binds to AT III and thrombin in a ternary complex, increasing the bimolecular rate constant for the inhibition of thrombin by a factor of 2000. Heparin is principally located in the granules of tissue mast cells that are closely associated with the immune response. Heparin makes numerous contacts with both FGF-2 and FGFR-1 stabilizing FGF-FGFR binding. Heparin also makes contacts with the FGFR-1 of the adjacent FGF-FGFR complex, thus seeming to promote FGFR dimerization[1].

[1]. Capila I, et al. Heparin-protein interactions. Angew Chem Int Ed Engl. 2002 Feb 1;41(3):391-412.